Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Carrà, Giuseppe
Crocamo, Cristina
Bartoli, Francesco
Lax, Annamaria
Tremolada, Martina
Lucii, Claudio
Martinotti, Giovanni
Nosè, Michela
Bighelli, Irene
Ostuzzi, Giovanni
Castellazzi, Mariasole
Clerici, Massimo
and
Barbui, Corrado
2016.
First-generation antipsychotics and QTc: any role for mediating variables?.
Human Psychopharmacology: Clinical and Experimental,
Vol. 31,
Issue. 4,
p.
313.
Alušík, Štefan
and
Paluch, Zoltán
2017.
Citalopram and QT prolongation.
Vnitřní lékařství,
Vol. 63,
Issue. 12,
p.
952.
Acciavatti, Tiziano
Martinotti, Giovanni
Corbo, Mariangela
Cinosi, Eduardo
Lupi, Matteo
Ricci, Fabrizio
Di Scala, Rosa
D’Ugo, Emilia
De Francesco, Viola
De Caterina, Raffaele
and
di Giannantonio, Massimo
2017.
Psychotropic drugs and ventricular repolarisation: The effects on QT interval, T-peak to T-end interval and QT dispersion.
Journal of Psychopharmacology,
Vol. 31,
Issue. 4,
p.
453.
Chue, Pierre S.
and
Siraki, Arno G.
2017.
A Worldwide Yearly Survey of New Data in Adverse Drug Reactions.
Vol. 39,
Issue. ,
p.
65.
Elliott, Anja
Mørk, Thibault Johan
Højlund, Mikkel
Christensen, Thomas
Jeppesen, Rasmus
Madsen, Nikolaj
Viuff, Anne Grethe
Hjorth, Peter
Nielsen, Jens Cosedis
and
Munk-Jørgensen, Povl
2018.
QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy.
CNS Spectrums,
Vol. 23,
Issue. 4,
p.
278.
Ostuzzi, Giovanni
Matcham, Faith
Dauchy, Sarah
Barbui, Corrado
and
Hotopf, Matthew
2018.
Antidepressants for the treatment of depression in people with cancer.
Cochrane Database of Systematic Reviews,
Vol. 2018,
Issue. 4,
Drago, Antonio
and
Kure Fischer, Ellen
2018.
A molecular pathway analysis informs the genetic risk for arrhythmias during antipsychotic treatment.
International Clinical Psychopharmacology,
Vol. 33,
Issue. 1,
p.
1.
Ozturk, Hayriye M
Erdogan, Mehmet
Alsancak, Yakup
Yarlioglues, Mikail
Duran, Mustafa
Boztas, M Hamid
Murat, Sani N
and
Ozturk, Selcuk
2018.
Electrocardiographic alterations in patients consuming synthetic cannabinoids.
Journal of Psychopharmacology,
Vol. 32,
Issue. 3,
p.
296.
Ostuzzi, Giovanni
Mazzi, Maria Angela
Terlizzi, Samira
Bertolini, Federico
Aguglia, Andrea
Bartoli, Francesco
Bortolaso, Paola
Callegari, Camilla
Caroleo, Mariarita
Carrà, Giuseppe
Corbo, Mariangela
D’Agostino, Armando
Gastaldon, Chiara
Lucii, Claudio
Magliocco, Fabio
Martinotti, Giovanni
Nosé, Michela
Ostinelli, Edoardo Giuseppe
Papola, Davide
Piccinelli, Marco Piero
Piccoli, Alberto
Purgato, Marianna
Tabacchi, Tommaso
Turrini, Giulia
Ruggeri, Mirella
Barbui, Corrado
and
Mazza, Marianna
2018.
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy.
PLOS ONE,
Vol. 13,
Issue. 8,
p.
e0201371.
Pugliese, Anna Maria
Coppi, Elisabetta
Cherchi, Federica
and
Pepeu, Giancarlo
2019.
Brain and Heart Dynamics.
p.
1.
Barbui, C.
and
Ostuzzi, G.
2019.
Medicine-based evidence: the case of antidepressants in patients with coronary artery disease.
Epidemiology and Psychiatric Sciences,
Vol. 28,
Issue. 1,
p.
18.
Waleekhachonloet, Onanong
Limwattananon, Chulaporn
and
Rattanachotphanit, Thananan
2019.
Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand.
Therapeutic Advances in Drug Safety,
Vol. 10,
Issue. ,
Ostuzzi, Giovanni
Turrini, Giulia
Gastaldon, Chiara
Papola, Davide
Rayner, Lauren
Caruso, Rosangela
Grassi, Luigi
Hotopf, Matthew
and
Barbui, Corrado
2019.
Efficacy and acceptability of antidepressants in patients with ischemic heart disease.
International Clinical Psychopharmacology,
Vol. 34,
Issue. 2,
p.
65.
Ali, Zahid
Ismail, Mohammad
Nazar, Zahid
Khan, Fahadullah
Khan, Qasim
and
Noor, Sidra
2020.
Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study.
BMC Psychiatry,
Vol. 20,
Issue. 1,
Pae, Chi-Un
2020.
Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?.
Chonnam Medical Journal,
Vol. 56,
Issue. 3,
p.
157.
Barbui, Corrado
Bertolini, Federico
Bartoli, Francesco
Calandra, Carmela
Callegari, Camilla
Carrà, Giuseppe
D’Agostino, Armando
Lucii, Claudio
Martinotti, Giovanni
Mastromo, Daniele
Moretti, Daniele
Monzani, Emiliano
Porcellana, Matteo
Prestia, Davide
and
Ostuzzi, Giovanni
2020.
Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study.
Therapeutic Advances in Psychopharmacology,
Vol. 10,
Issue. ,
Pugliese, Anna Maria
Coppi, Elisabetta
Cherchi, Federica
and
Pepeu, Giancarlo
2020.
Brain and Heart Dynamics.
p.
707.
Bomba, Monica
Nicosia, Franco
Riva, Anna
Corbetta, Fabiola
Conti, Elisa
Lanfranconi, Francesca
Tremolizzo, Lucio
and
Nacinovich, Renata
2020.
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents.
European Child & Adolescent Psychiatry,
Vol. 29,
Issue. 2,
p.
199.
Hefner, Gudrun
Hahn, Martina
Hiemke, Christoph
Toto, Sermin
Wolff, Jan
Roll, Sibylle C.
and
Klimke, Ansgar
2021.
Pharmacodynamic Drug–Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients.
Journal of Neural Transmission,
Vol. 128,
Issue. 2,
p.
243.
Wolff, Jan
Hefner, Gudrun
Normann, Claus
Kaier, Klaus
Binder, Harald
Domschke, Katharina
Hiemke, Christoph
Marschollek, Michael
and
Klimke, Ansgar
2021.
Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study.
BMJ Open,
Vol. 11,
Issue. 4,
p.
e045276.